OtherBASIC SCIENCE INVESTIGATIONS
Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer
Lakshmi Sampath, Sunkuk Kwon, Shi Ke, Wei Wang, Rachel Schiff, Michel E. Mawad and Eva M. Sevick-Muraca
Journal of Nuclear Medicine September 2007, 48 (9) 1501-1510; DOI: https://doi.org/10.2967/jnumed.107.042234
Lakshmi Sampath
Sunkuk Kwon
Shi Ke
Wei Wang
Rachel Schiff
Michel E. Mawad
In this issue
Journal of Nuclear Medicine
Vol. 48, Issue 9
September 2007
Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer
Lakshmi Sampath, Sunkuk Kwon, Shi Ke, Wei Wang, Rachel Schiff, Michel E. Mawad, Eva M. Sevick-Muraca
Journal of Nuclear Medicine Sep 2007, 48 (9) 1501-1510; DOI: 10.2967/jnumed.107.042234
Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer
Lakshmi Sampath, Sunkuk Kwon, Shi Ke, Wei Wang, Rachel Schiff, Michel E. Mawad, Eva M. Sevick-Muraca
Journal of Nuclear Medicine Sep 2007, 48 (9) 1501-1510; DOI: 10.2967/jnumed.107.042234
Jump to section
Related Articles
Cited By...
- Signal to Noise Ratio as a Cross-Platform Metric for Intraoperative Fluorescence Imaging
- Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody
- Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer
- Review on Production of 89Zr in a Medical Cyclotron for PET Radiopharmaceuticals
- Integrin {alpha}v{beta}3-Targeted IRDye 800CW Near-Infrared Imaging of Glioblastoma
- Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies
- Intravitreal Concentrations of a Near-Infrared Fluorescence-Labeled Biotherapeutic Determined In Situ Using Confocal Scanning Laser Ophthalmoscopy
- Simultaneous PET and Multispectral 3-Dimensional Fluorescence Optical Tomography Imaging System
- Toward Molecular Imaging-Driven Drug Development in Oncology
- Fluorescently Labeled Anti-Epidermal Growth Factor Receptor Antibodies to Guide Surgical Resection of Head and Neck Cancers
- Towards detecting the HER-2 receptor and metabolic changes induced by HER-2-targeted therapies using medical imaging
- A Molecularly Targeted Theranostic Probe for Ovarian Cancer
- Molecular Imaging: 18F-FDG PET and a Whole Lot More
- Multimodality Molecular Imaging with Combined Optical and SPECT/PET Modalities